Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin.

Study Overview
=================
Brief Summary
-----------------
Serum homocysteine level in Acne patients before and after oral Isotretinoin and Correlation between serum level of homocysteine in acne patients before and after Oral isotretinoin treatment

Detailed Description
-----------------
Acne vulgaris is a common chronic inflammatory disease of the skin. It is found in about 80% of young adults and adolescents. It is a disease that affects the pilosebaceous units of the skin and may result in inflammatory or non-inflammatory lesions,Oral isotretinoin (13-cis-retinoic acid) is the only drug that counteracts all the pathogenetic mechanisms that contribute to the development of acne The standard dose of isotretinoin is 0.5 to 1 mg/kg per day for 4 months to a cumulative dose of 120-140 mg/kg is effective in the management of acne vulgaris The scope of our study is to detect serum homocysteine level in acne patient befor and after oral isotrtinoin treatment

Official Title
-----------------
Serum Homocysteine Level in Acne Patients Before and After Oral Isotretinoin

Conditions
-----------------
Acne Vulgaris

Intervention / Treatment
-----------------
* Drug: Isotretinoin


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients of both sexes with acne vulgaris Exclusion Criteria: Patients with history of malignancies. Patients with renal and hepatic dysfunction. Cardiac patient. Pregnant, lactating and female welling to have pregnancy in the period of study. Patient with absorption disorder. Patient with history of favism. Patient has already been treated with isotretinoin.

Ages Eligible for Study
-----------------
Minimum Age: 15 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: group of patients and group of control
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Patient group<br>Patients were treated with Isotretinoin in a dose (from 20 to 40) for 3 months and serum homocysteine were assessed before and after treatment | Drug: Isotretinoin<br>* Isotretinoin is a vitamin-A derivative for treatment of moderate to severe acne used in a dose from 20-40 mg for 3 months duration<br>|
| No Intervention: Control group<br>Assessment of serum YKL40 in healthy individuals | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluation of the effect of oral isotretinoin on Serum homocysteine in acne vulgaris patients | Assessment in serum level homocysteine level in acne vulgaris patients after isotretinoin therapy with assesment of its level before starting therapy for detecting changes in serum homocysteine and effect of isotretinoin therapy on it. | 3 months |